Itrasys SB 130mg Capsule contains itraconazole, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the management of systemic and superficial mycoses, including aspergillosis, histoplasmosis, blastomycosis, onychomycosis, and other dermatophytic infections. Itrasys SB 130mg Capsule is particularly effective against infections caused by Candida species and dermatophytes. The capsule formulation ensures optimal bioavailability and convenient oral administration. It is important to adhere to the prescribed dosage and duration to achieve therapeutic efficacy and minimize resistance development. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, and abdominal pain, as well as potential hepatic enzyme elevation; therefore, liver function monitoring is recommended during prolonged therapy. Itraconazole is contraindicated in patients with known hypersensitivity to azole antifungals and should be used cautiously in individuals with cardiac dysfunction due to its negative inotropic effects. Concomitant use with certain medications metabolized by cytochrome P450 enzymes may result in significant drug interactions. Consultation with a healthcare professional is essential before initiating treatment with Itrasys SB 130mg Capsule.